• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症综合征中革兰氏阴性菌血症的发病率。对免疫治疗的影响。

Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.

作者信息

Willatts S M, Speller D C, Winter R J

机构信息

Intensive Therapy Unit, Bristol Royal Infirmary.

出版信息

Anaesthesia. 1994 Sep;49(9):751-4. doi: 10.1111/j.1365-2044.1994.tb04443.x.

DOI:10.1111/j.1365-2044.1994.tb04443.x
PMID:7978126
Abstract

The incidence of Gram-negative bacteraemia in 100 patients with sepsis syndrome receiving antibiotics, and admitted to the Intensive Therapy Unit, was only 12%. If endotoxin antibody is only effective in bacteraemic patients and these results are confirmed, there would be little indication for its use in our Intensive Therapy Unit.

摘要

在100例接受抗生素治疗并入住重症监护病房的脓毒症综合征患者中,革兰氏阴性菌血症的发生率仅为12%。如果内毒素抗体仅对菌血症患者有效且这些结果得到证实,那么在我们的重症监护病房使用它的指征就很少了。

相似文献

1
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.脓毒症综合征中革兰氏阴性菌血症的发病率。对免疫治疗的影响。
Anaesthesia. 1994 Sep;49(9):751-4. doi: 10.1111/j.1365-2044.1994.tb04443.x.
2
Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial.抗内毒素药物牛磺罗定治疗脓毒症综合征的效果:一项安慰剂对照双盲试验。
Crit Care Med. 1995 Jun;23(6):1033-9. doi: 10.1097/00003246-199506000-00007.
3
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.一项随机双盲对照试验,评估牛磺罗定-柠檬酸盐导管封管液在预防血液透析患者菌血症中的作用。
Am J Kidney Dis. 2010 Jun;55(6):1060-8. doi: 10.1053/j.ajkd.2009.11.025. Epub 2010 Mar 6.
4
Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit.重症监护病房中脓毒症综合征患者的内毒素血症和菌血症。
Chest. 1994 Oct;106(4):1194-201. doi: 10.1378/chest.106.4.1194.
5
Monoclonal antibodies for gram-negative sepsis.
Med Lett Drugs Ther. 1991 Nov 1;33(856):103-4.
6
Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsis.革兰氏阴性菌败血症高危患者的败血症综合征及相关后遗症。
Pharmacotherapy. 1995 Jan-Feb;15(1):66-77.
7
Novel approaches to the treatment of sepsis: lessons learned and future directions.
Shock. 1996;6 Suppl 1:S71-4.
8
Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.用于检测脓毒症综合征患者内毒素的鲎试剂检测法。AMCC脓毒症项目工作组。
Clin Infect Dis. 1998 Sep;27(3):582-91. doi: 10.1086/514713.
9
Clinical studies on administration of taurolin in severe sepsis: a preliminary study.牛磺罗宁治疗严重脓毒症的临床研究:一项初步研究。
Prog Clin Biol Res. 1988;272:361-71.
10
Antibody to endotoxin in the treatment of gram-negative sepsis.内毒素抗体治疗革兰氏阴性菌败血症。
JAMA. 1992 May 6;267(17):2325-6. doi: 10.1001/jama.1992.03480170051016.

引用本文的文献

1
Cytokines in the systemic inflammatory response syndrome: a review.全身炎症反应综合征中的细胞因子:综述
HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(3):161-75.
2
The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?手术患者实验性和临床脓毒症中内毒素释放的意义——抗生素诱导内毒素释放的证据?
Infection. 1998 Mar-Apr;26(2):77-84. doi: 10.1007/BF02767765.